703 - Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with moderate and/or more extensive atopic dermatitis: subgroup analysis from the TRuE-AD3 study

Authors

Andrea Zaenglein

Publication/Presentation Date

8-2024

Volume

191

Issue

2

Published In/Presented At

https://doi.org/10.1093/bjd/ljae266.077

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine Faculty

Document Type

Article